{"gene":"VPS33B","run_date":"2026-06-11T09:02:06","timeline":{"discoveries":[{"year":2004,"finding":"VPS33B encodes a homolog of yeast class C vacuolar protein sorting gene Vps33 and contains a Sec1-like domain important in regulation of vesicle-to-target SNARE complex formation and subsequent membrane fusion. Loss-of-function mutations cause ARC syndrome.","method":"Positional cloning, mutation identification in 14 kindreds, sequence domain analysis","journal":"Nature genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — disease-gene linkage with domain analysis; mechanistic inference from homology supported by disease mutations, single study","pmids":["15052268"],"is_preprint":false},{"year":2005,"finding":"VPS33B is required for megakaryocyte and platelet alpha-granule biogenesis but not granule secretion. VPS33B colocalizes with alpha-granule markers and late endosomes/lysosomes in megakaryocytes, and VPS33B protein is absent in ARC patient fibroblasts and megakaryocytes, resulting in complete absence of alpha-granules and loss of both soluble and membrane-bound alpha-granule proteins.","method":"Immunofluorescence microscopy, immunoblotting, platelet ultrastructural analysis, platelet aggregation assays in ARC patients","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (immunofluorescence, electron microscopy, functional aggregation assays, immunoblotting) in patient samples","pmids":["16123220"],"is_preprint":false},{"year":2005,"finding":"Zebrafish vps33b acts downstream of the hnf6/vhnf1 transcription factor pathway to regulate biliary development; vhnf1 directly binds the vps33b promoter as shown by EMSA, and vps33b knockdown causes bile duct paucity and impaired intestinal lipid absorption.","method":"Morpholino knockdown in zebrafish, EMSA, gene expression analysis, reporter assay in mammalian liver cells","journal":"Development (Cambridge, England)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — EMSA for direct promoter binding, morpholino KD phenotype, multiple methods in single lab","pmids":["16284120"],"is_preprint":false},{"year":2008,"finding":"VPS33B deficiency results in failure of lamellar granule secretion at the granular-cornified cell layer boundary in skin, with lamellar granules becoming entombed in cornified cells rather than being secreted, causing ichthyosis in ARC syndrome.","method":"Ultrastructural electron microscopy of patient skin, VPS33B mutation sequencing and splice analysis","journal":"Archives of dermatology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ultrastructural analysis directly linking VPS33B mutation to lamellar granule secretion defect, single lab","pmids":["18347289"],"is_preprint":false},{"year":2012,"finding":"VPS33B interacts with VIPAS39 (SPE-39). Wild-type and disease-causing mutations in VIPAS39 and Vps33B were studied; most ARC mutations do not prevent the VIPAS39-Vps33B interaction, but all tested mutants alter subcellular localization of Vps33B to VIPAS39-positive endosomes and some fragment VIPAS39-positive endosomes.","method":"Yeast two-hybrid, co-immunoprecipitation, quantitative fluorescent microscopy","journal":"Human molecular genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — yeast two-hybrid and co-IP with localization, single lab, multiple orthogonal methods","pmids":["23918659"],"is_preprint":false},{"year":2012,"finding":"VPS33B binds to VPS16B (encoded by C14orf133/VIPAS39); this interaction was identified by yeast two-hybrid, mass spectrometry, and coimmunoprecipitation. VPS16B colocalizes with markers of the trans-Golgi network, late endosomes, and alpha-granules in megakaryocytic Dami cells, similar to VPS33B, and VPS16B mutations cause alpha-granule biogenesis defects identical to VPS33B mutations.","method":"Yeast two-hybrid, mass spectrometry, coimmunoprecipitation, immunofluorescence microscopy, immunoblotting, patient platelet electron microscopy","journal":"Blood","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — multiple orthogonal methods (Y2H, MS, co-IP, microscopy, patient samples) in one study with reciprocal validation","pmids":["23002115"],"is_preprint":false},{"year":2012,"finding":"Association of VPS33B with SPE-39 (VIPAS39) inhibits ubiquitination of SPE-39 following EGF stimulation, stabilizing SPE-39. Tyrosine phosphorylation of SPE-39 at Tyr-11 regulates its ubiquitination. VPS33B and SPE-39 have opposing effects on EGF receptor downregulation in EGF-stimulated cells.","method":"Ubiquitination assays, phosphorylation analysis, co-immunoprecipitation, EGF receptor downregulation assays in COS-7 cells","journal":"FEBS letters","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP and functional assays showing opposing roles on EGFR downregulation, single lab","pmids":["22677173"],"is_preprint":false},{"year":2015,"finding":"VPS33B deficiency in mouse megakaryocytes causes accumulation of large vacuoles and reduction in mature type-II multivesicular bodies (MVB II), with alpha-granule proteins underrepresented in MVB II and proplatelet extensions, demonstrating that VPS33B is required for protein trafficking into alpha-granule progenitor organelles and MVB maturation.","method":"Tamoxifen-inducible conditional Vps33b knockout mouse model, conventional and immuno-electron microscopy, immunofluorescence, platelet aggregation and secretion assays, tail bleeding","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 / Strong — inducible KO mouse model with immuno-EM defining specific organelle defect, multiple orthogonal methods","pmids":["25947942"],"is_preprint":false},{"year":2015,"finding":"VPS33B depletion in HeLa cells leads to accumulation of late endosomes in the perinuclear region and impairs late endosomal-lysosomal fusion, resulting in decreased delivery of endocytosed cargo to lysosomes and reduced cargo degradation.","method":"siRNA knockdown, fluorescence and electron microscopy, BSA-gold endocytosis tracking, organelle quantification","journal":"Traffic (Copenhagen, Denmark)","confidence":"High","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods (fluorescence and EM, cargo tracking) in KD cells, demonstrating specific late endosome–lysosome fusion defect","pmids":["26403612"],"is_preprint":false},{"year":2015,"finding":"VPS33B binds directly to the integrin beta subunit. VPS33B overexpression in CHO cells potentiates alphaIIbbeta3 outside-in signaling but not inside-out signaling. Megakaryocyte/platelet-specific VPS33B conditional KO mice show impaired platelet spreading on fibrinogen, defective clot retraction, reduced platelet aggregation, and defective fibrinogen endocytosis. VPS33B acts upstream of the RhoA-ROCK-MLC and Rac1-dependent pathways.","method":"Co-immunoprecipitation/direct binding assay, CHO cell overexpression, conditional KO mouse model, platelet spreading/aggregation/clot retraction assays, FeCl3 thrombosis model, tail bleeding","journal":"Circulation","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct binding assay, conditional KO with multiple functional readouts and epistasis to RhoA/Rac1 pathways","pmids":["26399659"],"is_preprint":false},{"year":2016,"finding":"VPS33B interacts with VIPAS39 (SPE-39) and with alpha-tubulin and SEC22B; pull-down experiments showed VIPAS39 binds intact VPS33B whereas alpha-tubulin and SEC22B separately interact with the Sec1-like domains of VPS33B. VPS33B deficiency disrupts redistribution of Vipas39 and Sec22b to proplatelets and interrupts co-localization of Sec22b with VWF-positive vesicles in megakaryocytes.","method":"Co-immunoprecipitation, mass spectrometry, pull-down assay, immunoblotting in HEK293T cells; conditional Vps33b KO mice; immunofluorescence microscopy","journal":"The Journal of pathology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pull-down and co-IP identifying domain-specific interactions, supported by KO mouse localization data, single lab","pmids":["27319744"],"is_preprint":false},{"year":2016,"finding":"Drosophila and mammalian Vps33B proteins are required for maturation of phagosomes and endosomes following microbial (PRR) recognition. Vps33B deficiency specifically impairs clearance of endosomes containing internalized PRRs, resulting in enhanced and prolonged inflammatory signaling. Vps33B loss had no effect on trafficking of endosomes containing non-microbial cargo.","method":"Drosophila and mammalian Vps33B mutant/knockdown models, phagosome/endosome maturation assays, TLR signaling assays, cytokine/inflammatory mediator measurements","journal":"Immunity","confidence":"High","confidence_rationale":"Tier 2 / Strong — replicated in two organisms with specific cargo-selective phenotype established by KO and KD with functional readouts","pmids":["27496733"],"is_preprint":false},{"year":2016,"finding":"VPS33B controls exosome maturation and secretion in hematopoietic stem cells. VPS33B co-exists in exosomes with GDI2, VPS16B, FLOT1, and other exosome markers. Mechanistically, VPS33B interacts with the GDI2/RAB11A/RAB27A pathway to regulate trafficking of secretory proteins as exosomes. VPS33B deletion in mouse or human HSCs results in impaired exosome maturation and secretion and loss of stemness.","method":"Conditional VPS33B deletion in mouse and human HSCs, exosome purification and characterization, co-immunoprecipitation, rescue experiments with purified exosomes","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 2 / Strong — KO in two species, co-IP identifying pathway components (GDI2/RAB11A/RAB27A), rescue experiment, multiple orthogonal methods","pmids":["27797340"],"is_preprint":false},{"year":2016,"finding":"The p.Gly131Glu mutant VPS33B has reduced coimmunoprecipitation and colocalization with Rab11a and Rab25 and fails to rescue LH3 (lysyl hydroxylase 3) trafficking. Wild-type VPS33B interacts with Rab11a and Rab25 proteins and is involved in trafficking of the collagen-modifying enzyme LH3; deficiency leads to deficient LH3-specific collagen lysine modifications.","method":"Co-immunoprecipitation, colocalization microscopy, LH3 trafficking rescue assay, collagen lysine modification analysis in patient urine and fibroblasts, VPS33B mutant construct analysis","journal":"The Journal of investigative dermatology","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (co-IP, colocalization, functional rescue assay, biochemical modification analysis) linking VPS33B-Rab11a/Rab25 interaction to LH3 trafficking","pmids":["28017832"],"is_preprint":false},{"year":2017,"finding":"Liver-specific Vps33b deletion in mice causes mislocalisation of ATP-binding cassette (ABC) proteins that are trafficked to the apical membrane via Rab11a-positive recycling endosomes, resulting in loss of structural and functional hepatocyte polarity. VPS33B interacts with RAB11A at recycling endosomes. Gene transfer with AAV vectors partially rescued these defects.","method":"Liver-specific conditional Vps33b KO mouse, bile/plasma metabolite analysis by mass spectrometry, immunostaining, light/transmission electron microscopy, AAV gene rescue","journal":"Journal of hepatology","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional KO with functional (bile transport), structural (EM), and molecular (protein localization) readouts plus gene rescue, multiple orthogonal methods","pmids":["28082148"],"is_preprint":false},{"year":2018,"finding":"VPS33B and VIPAR are essential for epidermal lamellar body biogenesis and function. Vps33b and Vipar deficient mouse skin shows abnormal lamellar body morphology, disrupted localisation of lamellar body cargo, increased corneocyte thickness, decreased cornified envelope thickness, and reduced lipid deposition, causing impaired epidermal barrier.","method":"Vps33b and Vipar KO mice, histology, immunofluorescence, electron microscopy, primary cell culture","journal":"Biochimica et biophysica acta. Molecular basis of disease","confidence":"High","confidence_rationale":"Tier 2 / Strong — two KO mouse models with histological, ultrastructural, and immunofluorescence analysis, multiple orthogonal methods","pmids":["29409756"],"is_preprint":false},{"year":2018,"finding":"VPS33B does not associate with CORVET or HOPS complex subunits. Instead, VPS33B forms a distinct and small complex with VIPAR. VPS33B also interacts directly with CCDC22, a member of the CCC complex, but this interaction is transient rather than forming a stable complex. CCDC22 does not co-fractionate with VPS33B and VIPAR in gel filtration, and the VPS33B-VIPAR complex is considerably smaller than CORVET/HOPS.","method":"BioID proximity biotinylation assay, gel filtration chromatography, comparative interactome analysis of VPS33A and VPS33B","journal":"Journal of molecular biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — BioID and gel filtration provide orthogonal evidence; single lab; negative result for CORVET/HOPS association informative","pmids":["29778605"],"is_preprint":false},{"year":2019,"finding":"The VPS33B-VPS16B complex forms a distinct small complex with the same hydrodynamic radius as the recombinant heterodimer purified from bacteria. In megakaryocyte cells, VPS33B deficiency results in alpha-granule cargo (PF4, VWF, P-selectin) degradation in lysosomes rather than delivery to alpha-granules. The VPS33B-VPS16B complex localizes to the recycling endosome, identifying the recycling endosome as a key intermediate compartment in alpha-granule biogenesis. VPS16B steady-state levels are reduced in VPS33B-KO cells, indicating VPS16B is destabilized without its partner.","method":"CRISPR/Cas9 KO in iPSC-derived immortalized megakaryocyte cells (imMKCLs), size exclusion chromatography, recombinant protein purification from bacteria, GFP-VPS33B reconstitution, cargo trafficking analysis, lysosomal inhibitor experiments","journal":"Blood advances","confidence":"High","confidence_rationale":"Tier 1 / Strong — recombinant protein purification, CRISPR KO, reconstitution with GFP-VPS33B, and lysosomal degradation assays provide multiple orthogonal mechanistic insights in one study","pmids":["31501156"],"is_preprint":false},{"year":2019,"finding":"A missense mutation p.Cys576Arg in VPS33B abolishes interaction with VIPAS39 in vitro, as demonstrated by co-immunoprecipitation.","method":"In vitro co-immunoprecipitation with mutant VPS33B constructs, protein expression analysis","journal":"Human mutation","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — single co-IP experiment demonstrating abolished VIPAR interaction for specific mutation, single lab","pmids":["31479177"],"is_preprint":false},{"year":2020,"finding":"Vps33B loss-of-function in Drosophila results in hypersensitivity to infection driven by aberrant p38b MAP kinase activation downstream of PGRP-LC receptor. p38b MAPK modulates endosomal trafficking of PGRP-LC and phagocytosis of bacteria; constitutively active p38b enhances accumulation of endocytosed PGRP-LC, and p38b is required for macropinocytosis-mediated downregulation of immune receptors.","method":"Drosophila Vps33B mutant flies, p38b MAPK epistasis experiments (constitutively active/dominant negative constructs), endosomal trafficking assays, phagocytosis assays, survival assays","journal":"Traffic (Copenhagen, Denmark)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic epistasis with constitutively active/dominant negative constructs and functional assays, single lab in Drosophila model","pmids":["32677257"],"is_preprint":false},{"year":2022,"finding":"VPS16B/VPS33B complex physically associates with Syntaxin 12 (Stx12), a SNARE protein mediating vesicle fusion at endosomes. VPS16B/VPS33B also binds CCDC22 (CCC complex). CCDC22 competes with Stx12 for binding to VPS16B/VPS33B, suggesting a hand-off mechanism between endosomal entry (Stx12-mediated fusion) and exit (CCC-mediated retrieval). COMMD3-containing CCC complex deficiency causes reduced alpha-granule numbers and loss of alpha-granule proteins, with P-selectin trafficked through the cell surface in a COMMD3-dependent manner.","method":"Co-immunoprecipitation, CRISPR/Cas9 KO of Stx12 and COMMD3/CCDC22 in megakaryocyte cells, immunofluorescence, alpha-granule protein quantitation, flow cytometry","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple co-IPs and CRISPR KOs with functional granule phenotypes, competition assay for hand-off mechanism, single lab with multiple orthogonal methods","pmids":["34905616"],"is_preprint":false},{"year":2022,"finding":"Treg-specific depletion of Vps33B in mice results in defective Treg cell suppressive function and acquisition of effector phenotype. Mechanistically, Vps33B binds the lysosomal nutrient-sensing complex (LYNUS) and promotes late endosome-lysosome fusion and clearance of LYNUS-containing late endosome/lysosomes, thereby suppressing mTORC1 activation. Vps33B deficiency causes disordered endosome-lysosome fusion, accumulation of LYNUS, elevated mTORC1 activation, and hyper-glycolytic metabolism in Treg cells.","method":"Treg-specific conditional KO mice, mTORC1 activity assays, glycolytic metabolism measurement, endolysosomal fusion assays, co-immunoprecipitation of Vps33B with LYNUS components, T cell suppression assays, tumor models","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional KO, co-IP demonstrating LYNUS interaction, mTORC1 functional readout, multiple orthogonal mechanistic methods","pmids":["35705052"],"is_preprint":false},{"year":2022,"finding":"In ARC syndrome patient platelets with VPS33B loss-of-function, VPS16B protein expression is also lost, indicating that stable expression of VPS16B in platelets and megakaryocytes is dependent on VPS33B.","method":"Immunoblotting of patient platelets, electron microscopy, genetic analysis of novel VPS33B variant","journal":"Journal of thrombosis and haemostasis : JTH","confidence":"Medium","confidence_rationale":"Tier 3 / Weak — single patient primary cell immunoblotting; finding consistent with CRISPR data from other labs but single case","pmids":["35325493"],"is_preprint":false},{"year":2023,"finding":"Human VPS33B-VPS16B forms a high molecular weight complex (~315 kDa) with a VPS33B:VPS16B ratio of 2:3 and a uniquely bidirectional two-lobed structure, each lobe containing a VPS33B molecule oriented in opposite directions. This architecture allows VPS33B at each end to potentially interact with separate SNARE bundles/SNAREpins. The ARC-causing variant L30P disrupts complex formation, whereas S243F and H344D do not. Truncated VPS16B (amino acids 143-316) is sufficient to form a complex with VPS33B.","method":"Recombinant protein expression in yeast, circular dichroism, SEC-MALS, quantitative immunoblotting, small-angle X-ray scattering, negative-staining EM, avidin tagging, ARC variant expression analysis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — reconstitution with multiple structural methods (CD, SEC-MALS, SAXS, negative-stain EM) plus mutagenesis establishing structure-function relationships","pmids":["37062417"],"is_preprint":false},{"year":2023,"finding":"METTL16 methyltransferase induces m6A modification of VPS33B mRNA, impairing VPS33B transcript stability and reducing VPS33B protein levels. This was identified as a downstream regulatory mechanism controlling VPS33B expression in osteosarcoma.","method":"m6A modification assays, mRNA stability assays, METTL16 knockdown/overexpression, VPS33B knockdown rescue experiments","journal":"Journal of cellular physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct m6A modification of VPS33B mRNA identified with functional stability readout, single lab","pmids":["37357526"],"is_preprint":false},{"year":2026,"finding":"VPS33B knockout in proximal tubular epithelial cells (RPTEC-TERT1) causes a 'peeling' phenotype with altered cell-matrix adhesion and transcriptional changes in adhesion-related genes.","method":"CRISPR/Cas9 KO, brightfield imaging, immunostaining, RNA sequencing, cell detachment assays","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — CRISPR KO with multiple methods (imaging, RNA-seq, functional assay) but single lab; transcriptional changes without direct molecular mechanism identified","pmids":["41686830"],"is_preprint":false},{"year":2026,"finding":"VPS33B is required for optimal MHC class II antigen presentation in dendritic cells. VPS33B-deficient DCs predominantly express MHC class II loaded with invariant chain degradation intermediates rather than mature peptide-loaded complexes, impairing CD4 T cell priming while not affecting MHC class I-dependent CD8 T cell priming.","method":"DC-specific conditional KO, MHC class II peptide presentation assays, CD4 and CD8 T cell priming assays, flow cytometry, immunostaining","journal":"iScience","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional KO with specific mechanistic readout (invariant chain degradation intermediate accumulation), selective class II vs class I effect established by multiple T cell assays","pmids":["42231978"],"is_preprint":false}],"current_model":"VPS33B is a Sec1/Munc18 family protein that forms a uniquely bidirectional ~315 kDa heteromeric complex (2:3 ratio) with VPS16B/VIPAR, enabling interaction with SNARE complexes at both ends to regulate vesicle-to-target membrane fusion; it acts at recycling endosomes and late endosomal-lysosomal fusion steps to direct trafficking of diverse cargo—including alpha-granule proteins in megakaryocytes, apical ABC transporters in hepatocytes, lamellar body contents in keratinocytes, collagen-modifying enzyme LH3, PRR-containing endosomes in innate immune cells, and MHC class II complexes in dendritic cells—through interactions with Rab11a, Rab25, Rab27a, GDI2, SNARE proteins (SEC22B, Syntaxin 12), integrin beta subunits, the CCC/COMMD3 complex, and the lysosomal nutrient-sensing complex (LYNUS), with loss of function causing ARC syndrome due to defective vesicular protein sorting across multiple tissues."},"narrative":{"mechanistic_narrative":"VPS33B is a Sec1/Munc18 (SM)-family vesicle trafficking regulator that controls protein sorting at recycling endosomes and the late endosome–lysosome interface across multiple specialized cell types [PMID:15052268, PMID:26403612]. Rather than associating with the canonical CORVET/HOPS tethering complexes, it forms a distinct, stable heteromeric complex with VPS16B/VIPAS39 (VIPAR), a partnership essential for its activity and for the reciprocal stabilization of VPS16B, which is destabilized and lost when VPS33B is absent [PMID:23002115, PMID:29778605, PMID:31501156, PMID:35325493]. Structurally this complex is a ~315 kDa, two-lobed bidirectional assembly with a 2:3 VPS33B:VPS16B stoichiometry, an architecture that positions a VPS33B molecule at each end to engage SNARE machinery, consistent with its physical association with SNARE proteins SEC22B and Syntaxin 12 [PMID:27319744, PMID:34905616, PMID:37062417]. The complex directs cargo through Rab-dependent recycling pathways—binding Rab11a and Rab25 and the GDI2/RAB11A/RAB27A axis—to traffic diverse cargo: alpha-granule proteins in megakaryocytes, apical ABC transporters in hepatocytes, lamellar body contents in keratinocytes, and the collagen-modifying enzyme LH3 [PMID:27797340, PMID:28017832, PMID:28082148, PMID:29409756]. At the late endosome–lysosome step VPS33B promotes fusion and cargo clearance, controlling delivery of endocytosed cargo for degradation, clearance of pattern-recognition-receptor-containing endosomes to limit inflammatory signaling, turnover of the LYNUS complex to restrain mTORC1 activation in regulatory T cells, and MHC class II maturation in dendritic cells [PMID:26403612, PMID:27496733, PMID:35705052, PMID:42231978]. In megakaryocytes loss of VPS33B misroutes alpha-granule cargo to lysosomal degradation rather than to alpha-granule progenitor organelles, defining the recycling endosome as a key biogenesis intermediate; a competitive hand-off between Syntaxin 12 and the COMMD3/CCC retrieval complex couples endosomal entry to exit [PMID:25947942, PMID:31501156, PMID:34905616]. Loss-of-function mutations in VPS33B cause ARC syndrome (arthrogryposis–renal dysfunction–cholestasis), reflecting defective vesicular sorting across megakaryocytes, hepatocytes, and skin [PMID:15052268, PMID:16123220, PMID:18347289].","teleology":[{"year":2004,"claim":"Established the molecular identity of VPS33B as a Sec1-like SM-family trafficking protein and linked its loss of function to a human multisystem disorder, framing the gene as a regulator of SNARE-mediated membrane fusion.","evidence":"Positional cloning and mutation analysis in 14 ARC kindreds with sequence domain analysis","pmids":["15052268"],"confidence":"Medium","gaps":["Direct biochemical demonstration of SNARE regulation not shown","Tissue-specific trafficking roles undefined","No interacting partners identified"]},{"year":2005,"claim":"Demonstrated that VPS33B is required for alpha-granule biogenesis but not secretion, providing the first concrete cellular trafficking defect underlying an ARC phenotype.","evidence":"Immunofluorescence, immunoblotting, platelet ultrastructure and aggregation assays in ARC patient cells","pmids":["16123220"],"confidence":"High","gaps":["Molecular partners mediating granule cargo sorting unknown","Compartment where sorting fails not yet defined"]},{"year":2005,"claim":"Placed vps33b downstream of a transcriptional cascade in biliary development, connecting its trafficking function to organ morphogenesis.","evidence":"Morpholino knockdown in zebrafish, EMSA promoter binding, reporter assays","pmids":["16284120"],"confidence":"Medium","gaps":["Mechanism connecting trafficking to bile duct formation unresolved","Mammalian relevance of transcriptional control untested"]},{"year":2008,"claim":"Extended the secretory trafficking defect to skin, showing lamellar granule secretion fails in VPS33B deficiency, explaining the ichthyosis component of ARC.","evidence":"Ultrastructural EM of patient skin with mutation/splice analysis","pmids":["18347289"],"confidence":"Medium","gaps":["Molecular step blocking lamellar granule secretion undefined","Partner proteins not identified"]},{"year":2012,"claim":"Identified VPS16B/VIPAS39 as the principal VPS33B partner, showing both proteins co-localize and that VIPAS39 mutations phenocopy VPS33B loss, establishing the functional complex.","evidence":"Yeast two-hybrid, mass spectrometry, co-IP, immunofluorescence, patient platelet EM","pmids":["23002115","23918659"],"confidence":"High","gaps":["Stoichiometry and architecture of complex unknown","Whether complex includes CORVET/HOPS subunits unresolved"]},{"year":2012,"claim":"Linked VPS33B-VIPAS39 association to receptor regulation, showing the interaction stabilizes VIPAS39 and the two proteins exert opposing effects on EGFR downregulation.","evidence":"Ubiquitination/phosphorylation assays, co-IP and EGFR downregulation assays in COS-7 cells","pmids":["22677173"],"confidence":"Medium","gaps":["Physiological relevance of opposing EGFR effects unclear","Connection to multisystem ARC phenotypes not established"]},{"year":2015,"claim":"Defined the organellar step VPS33B controls in megakaryocytes (MVB maturation/cargo entry) and in generic cells (late endosome–lysosome fusion), converging on a conserved fusion function.","evidence":"Inducible Vps33b KO mouse with immuno-EM; siRNA knockdown with cargo tracking and EM in HeLa","pmids":["25947942","26403612"],"confidence":"High","gaps":["Direct SNARE/fusion machinery at these steps not yet identified","Cargo selectivity mechanism unclear"]},{"year":2015,"claim":"Showed VPS33B binds the integrin beta subunit and functions in platelet outside-in signaling and fibrinogen endocytosis, extending its role beyond granule biogenesis to receptor trafficking and cytoskeletal signaling.","evidence":"Direct binding assay, CHO overexpression, conditional KO mice, spreading/clot retraction/thrombosis assays","pmids":["26399659"],"confidence":"High","gaps":["Structural basis of integrin binding undefined","How trafficking role couples to RhoA/Rac1 signaling unresolved"]},{"year":2016,"claim":"Mapped domain-specific interactions, showing VIPAS39 binds intact VPS33B while alpha-tubulin and SEC22B engage the Sec1-like domains, and that VPS33B operates within Rab11a/Rab25 and GDI2/RAB11A/RAB27A pathways.","evidence":"Co-IP, MS, pull-down in HEK293T; conditional KO mice; HSC exosome studies with rescue; LH3 trafficking rescue assays","pmids":["27319744","27797340","28017832"],"confidence":"High","gaps":["How Rab handoffs are coordinated mechanistically unclear","Whether SNARE binding is direct and which SNAREs predominate per tissue undefined"]},{"year":2016,"claim":"Established cargo-selective, infection-specific function, showing VPS33B is required for maturation of PRR-containing endosomes/phagosomes and restrains inflammatory signaling, conserved from Drosophila to mammals.","evidence":"Drosophila and mammalian mutant/knockdown models, maturation assays, TLR signaling and cytokine measurements","pmids":["27496733"],"confidence":"High","gaps":["Mechanism distinguishing microbial from non-microbial cargo unknown","Upstream sensors triggering selective VPS33B engagement undefined"]},{"year":2017,"claim":"Demonstrated hepatocyte apical polarity depends on VPS33B-mediated Rab11a recycling-endosome trafficking of ABC transporters, with AAV gene transfer offering partial rescue.","evidence":"Liver-specific conditional KO, bile metabolite MS, immunostaining, EM, AAV rescue","pmids":["28082148"],"confidence":"High","gaps":["Direct VPS33B-cargo recognition mechanism unresolved","Durability/scalability of gene therapy untested"]},{"year":2018,"claim":"Clarified the complex identity: VPS33B does not associate with CORVET/HOPS but forms a small VPS33B-VIPAR complex with only transient CCC (CCDC22) contact, distinguishing it biochemically from its paralog VPS33A.","evidence":"BioID, gel filtration, comparative VPS33A/VPS33B interactome analysis","pmids":["29778605"],"confidence":"Medium","gaps":["Precise stoichiometry not resolved here","Functional consequence of transient CCC contact undefined"]},{"year":2018,"claim":"Confirmed VPS33B-VIPAR jointly drive epidermal lamellar body biogenesis and barrier formation in mammals, validating the shared-complex model in skin.","evidence":"Vps33b and Vipar KO mice, histology, immunofluorescence, EM, primary culture","pmids":["29409756"],"confidence":"High","gaps":["Molecular cargo-loading step into lamellar bodies undefined","Lipid-handling mechanism not detailed"]},{"year":2019,"claim":"Resolved that the VPS33B-VPS16B complex is a discrete heterodimer-sized assembly localizing to recycling endosomes, and that without it alpha-granule cargo is misrouted to lysosomal degradation, identifying the recycling endosome as the key biogenesis intermediate.","evidence":"CRISPR KO in iPSC-derived megakaryocytes, SEC, recombinant protein, GFP-reconstitution, lysosomal inhibition","pmids":["31501156","31479177"],"confidence":"High","gaps":["Atomic structure not yet determined here","Mechanism diverting cargo away from lysosome unknown"]},{"year":2022,"claim":"Defined an entry/exit hand-off, showing CCDC22 (CCC) competes with Syntaxin 12 for the VPS16B/VPS33B complex and that COMMD3-containing CCC controls alpha-granule cargo retrieval, integrating SNARE-mediated fusion with endosomal sorting.","evidence":"Co-IP, CRISPR KO of Stx12 and COMMD3/CCDC22, immunofluorescence, granule protein quantitation","pmids":["34905616","35325493"],"confidence":"High","gaps":["Spatiotemporal regulation of the competition unresolved","Whether hand-off operates identically in non-platelet tissues untested"]},{"year":2022,"claim":"Revealed an immunometabolic role: VPS33B clears LYNUS-containing late endosomes/lysosomes to suppress mTORC1, sustaining regulatory T cell suppressive function and restraining glycolysis.","evidence":"Treg-specific conditional KO, mTORC1 and glycolysis assays, endolysosomal fusion assays, LYNUS co-IP, tumor models","pmids":["35705052"],"confidence":"High","gaps":["Direct LYNUS binding interface undefined","Whether mTORC1 control generalizes to other cell types untested"]},{"year":2023,"claim":"Determined the bidirectional two-lobed ~315 kDa 2:3 architecture of the complex, providing the structural rationale for VPS33B engaging SNARE bundles at both ends, and mapped ARC variants that do or do not disrupt assembly.","evidence":"Recombinant expression, CD, SEC-MALS, SAXS, negative-stain EM, avidin tagging, ARC variant analysis","pmids":["37062417"],"confidence":"High","gaps":["High-resolution structure with bound SNAREs lacking","Whether both lobes engage SNAREs simultaneously in vivo untested"]},{"year":2023,"claim":"Identified post-transcriptional control of VPS33B via METTL16-mediated m6A modification reducing transcript stability, providing a regulatory input in osteosarcoma.","evidence":"m6A and mRNA stability assays, METTL16 manipulation, VPS33B knockdown rescue","pmids":["37357526"],"confidence":"Medium","gaps":["Physiological context of this regulation beyond osteosarcoma unclear","Downstream trafficking consequences not detailed"]},{"year":2026,"claim":"Extended VPS33B function to dendritic cell MHC class II maturation, showing its loss causes accumulation of invariant-chain intermediates and selectively impairs CD4 priming, and to renal epithelial cell-matrix adhesion.","evidence":"DC-specific and RPTEC-TERT1 CRISPR/conditional KO, MHC peptide presentation and T cell priming assays, RNA-seq, adhesion assays","pmids":["42231978","41686830"],"confidence":"High","gaps":["Molecular step in invariant chain processing controlled by VPS33B undefined","Direct adhesion-pathway mechanism in renal cells not identified"]},{"year":null,"claim":"How the bidirectional VPS33B-VPS16B complex selects distinct cargo and SNARE partners across tissues, and the high-resolution structural basis for SNARE engagement, remain unresolved.","evidence":"","pmids":[],"confidence":"High","gaps":["No co-structure of the complex with SNAREs or Rab effectors","Mechanism of tissue-specific cargo selectivity unknown","Whether both lobes function simultaneously or sequentially undefined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[10,20,23]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[0,8]}],"localization":[{"term_id":"GO:0005768","term_label":"endosome","supporting_discovery_ids":[1,8,13,17]},{"term_id":"GO:0005764","term_label":"lysosome","supporting_discovery_ids":[8,17,21]},{"term_id":"GO:0031410","term_label":"cytoplasmic vesicle","supporting_discovery_ids":[7,12]}],"pathway":[{"term_id":"R-HSA-5653656","term_label":"Vesicle-mediated transport","supporting_discovery_ids":[8,11,14,17]},{"term_id":"R-HSA-9609507","term_label":"Protein localization","supporting_discovery_ids":[13,14]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[11,21,26]},{"term_id":"R-HSA-109582","term_label":"Hemostasis","supporting_discovery_ids":[1,7,9]}],"complexes":["VPS33B-VPS16B/VIPAR complex"],"partners":["VIPAS39","SEC22B","STX12","RAB11A","RAB25","GDI2","CCDC22","ITGB3"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q9H267","full_name":"Vacuolar protein sorting-associated protein 33B","aliases":[],"length_aa":617,"mass_kda":70.6,"function":"May play a role in vesicle-mediated protein trafficking to lysosomal compartments and in membrane docking/fusion reactions of late endosomes/lysosomes. Required for proper trafficking and targeting of the collagen-modifying enzyme lysyl hydroxylase 3 (LH3) to intracellular collagen (PubMed:28017832). Mediates phagolysosomal fusion in macrophages (PubMed:18474358). Proposed to be involved in endosomal maturation implicating VIPAS39. In epithelial cells, the VPS33B:VIPAS39 complex may play a role in the apical recycling pathway and in the maintenance of the apical-basolateral polarity (PubMed:20190753). Seems to be involved in the sorting of specific cargos from the trans-Golgi network to alpha-granule-destined multivesicular bodies (MVBs) promoting MVBs maturation in megakaryocytes (By similarity)","subcellular_location":"Late endosome membrane; Lysosome membrane; Early endosome; Cytoplasmic vesicle, clathrin-coated vesicle; Recycling endosome","url":"https://www.uniprot.org/uniprotkb/Q9H267/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/VPS33B","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"WASF2","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/VPS33B","total_profiled":1310},"omim":[{"mim_id":"620010","title":"CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 12; PFIC12","url":"https://www.omim.org/entry/620010"},{"mim_id":"620009","title":"KERATODERMA-ICHTHYOSIS-DEAFNESS SYNDROME, AUTOSOMAL RECESSIVE; KDIDAR","url":"https://www.omim.org/entry/620009"},{"mim_id":"616700","title":"COMM DOMAIN-CONTAINING PROTEIN 3; COMMD3","url":"https://www.omim.org/entry/616700"},{"mim_id":"613404","title":"ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2; ARCS2","url":"https://www.omim.org/entry/613404"},{"mim_id":"613401","title":"VPS33B-INTERACTING PROTEIN, APICAL-BASOLATERAL POLARITY REGULATOR, SPE39 HOMOLOG; VIPAS39","url":"https://www.omim.org/entry/613401"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/VPS33B"},"hgnc":{"alias_symbol":["FLJ14848"],"prev_symbol":[]},"alphafold":{"accession":"Q9H267","domains":[{"cath_id":"3.40.50.2060","chopping":"14-142","consensus_level":"high","plddt":95.1441,"start":14,"end":142},{"cath_id":"3.40.50.1910","chopping":"146-236_519-611","consensus_level":"high","plddt":95.0552,"start":146,"end":611},{"cath_id":"3.90.830.10","chopping":"257-358","consensus_level":"high","plddt":93.7435,"start":257,"end":358},{"cath_id":"1.25.40.850","chopping":"360-439","consensus_level":"high","plddt":96.3136,"start":360,"end":439}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9H267","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9H267-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9H267-F1-predicted_aligned_error_v6.png","plddt_mean":91.44},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=VPS33B","jax_strain_url":"https://www.jax.org/strain/search?query=VPS33B"},"sequence":{"accession":"Q9H267","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9H267.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9H267/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9H267"}},"corpus_meta":[{"pmid":"15052268","id":"PMC_15052268","title":"Mutations in VPS33B, encoding a regulator of SNARE-dependent membrane fusion, cause arthrogryposis-renal dysfunction-cholestasis (ARC) syndrome.","date":"2004","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/15052268","citation_count":243,"is_preprint":false},{"pmid":"16123220","id":"PMC_16123220","title":"Requirement of VPS33B, a member of the Sec1/Munc18 protein family, in megakaryocyte and platelet alpha-granule biogenesis.","date":"2005","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/16123220","citation_count":118,"is_preprint":false},{"pmid":"27797340","id":"PMC_27797340","title":"Sorting protein VPS33B regulates exosomal autocrine signaling to mediate hematopoiesis and leukemogenesis.","date":"2016","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/27797340","citation_count":76,"is_preprint":false},{"pmid":"23002115","id":"PMC_23002115","title":"The VPS33B-binding protein VPS16B is required in megakaryocyte and platelet α-granule biogenesis.","date":"2012","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/23002115","citation_count":65,"is_preprint":false},{"pmid":"30944308","id":"PMC_30944308","title":"VPS33B interacts with NESG1 to modulate EGFR/PI3K/AKT/c-Myc/P53/miR-133a-3p signaling and induce 5-fluorouracil sensitivity in nasopharyngeal carcinoma.","date":"2019","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/30944308","citation_count":57,"is_preprint":false},{"pmid":"16284120","id":"PMC_16284120","title":"Zebrafish vps33b, an ortholog of the gene responsible for human arthrogryposis-renal dysfunction-cholestasis syndrome, regulates biliary development downstream of the onecut transcription factor hnf6.","date":"2005","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/16284120","citation_count":50,"is_preprint":false},{"pmid":"25947942","id":"PMC_25947942","title":"VPS33B regulates protein sorting into and maturation of α-granule progenitor organelles in mouse megakaryocytes.","date":"2015","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/25947942","citation_count":44,"is_preprint":false},{"pmid":"28082148","id":"PMC_28082148","title":"Vps33b is crucial for structural and functional hepatocyte polarity.","date":"2017","source":"Journal of hepatology","url":"https://pubmed.ncbi.nlm.nih.gov/28082148","citation_count":41,"is_preprint":false},{"pmid":"18347289","id":"PMC_18347289","title":"Defective lamellar granule secretion in arthrogryposis, renal dysfunction, and cholestasis syndrome caused by a mutation in VPS33B.","date":"2008","source":"Archives of dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/18347289","citation_count":37,"is_preprint":false},{"pmid":"28017832","id":"PMC_28017832","title":"Autosomal Recessive Keratoderma-Ichthyosis-Deafness (ARKID) Syndrome Is Caused by VPS33B Mutations Affecting Rab Protein Interaction and Collagen Modification.","date":"2016","source":"The Journal of investigative dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/28017832","citation_count":36,"is_preprint":false},{"pmid":"26403612","id":"PMC_26403612","title":"Vps33B is required for delivery of endocytosed cargo to lysosomes.","date":"2015","source":"Traffic (Copenhagen, Denmark)","url":"https://pubmed.ncbi.nlm.nih.gov/26403612","citation_count":36,"is_preprint":false},{"pmid":"26399659","id":"PMC_26399659","title":"Characterization of a Novel Integrin Binding Protein, VPS33B, Which Is Important for Platelet Activation and In Vivo Thrombosis and Hemostasis.","date":"2015","source":"Circulation","url":"https://pubmed.ncbi.nlm.nih.gov/26399659","citation_count":32,"is_preprint":false},{"pmid":"19274792","id":"PMC_19274792","title":"Clinical characteristics and VPS33B mutations in patients with ARC syndrome.","date":"2009","source":"Journal of pediatric gastroenterology and nutrition","url":"https://pubmed.ncbi.nlm.nih.gov/19274792","citation_count":32,"is_preprint":false},{"pmid":"29409756","id":"PMC_29409756","title":"VPS33B and VIPAR are essential for epidermal lamellar body biogenesis and function.","date":"2018","source":"Biochimica et biophysica acta. Molecular basis of disease","url":"https://pubmed.ncbi.nlm.nih.gov/29409756","citation_count":30,"is_preprint":false},{"pmid":"16492441","id":"PMC_16492441","title":"VPS33B mutation with ichthyosis, cholestasis, and renal dysfunction but without arthrogryposis: incomplete ARC syndrome phenotype.","date":"2006","source":"The Journal of pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/16492441","citation_count":30,"is_preprint":false},{"pmid":"27496733","id":"PMC_27496733","title":"ARC Syndrome-Linked Vps33B Protein Is Required for Inflammatory Endosomal Maturation and Signal Termination.","date":"2016","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/27496733","citation_count":29,"is_preprint":false},{"pmid":"27319744","id":"PMC_27319744","title":"Vps33b regulates Vwf-positive vesicular trafficking in megakaryocytes.","date":"2016","source":"The Journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/27319744","citation_count":28,"is_preprint":false},{"pmid":"33425490","id":"PMC_33425490","title":"VPS33B modulates c-Myc/p53/miR-192-3p to target CCNB1 suppressing the growth of non-small cell lung cancer.","date":"2020","source":"Molecular therapy. Nucleic acids","url":"https://pubmed.ncbi.nlm.nih.gov/33425490","citation_count":24,"is_preprint":false},{"pmid":"29778605","id":"PMC_29778605","title":"Proteomic and Biochemical Comparison of the Cellular Interaction Partners of Human VPS33A and VPS33B.","date":"2018","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/29778605","citation_count":23,"is_preprint":false},{"pmid":"23918659","id":"PMC_23918659","title":"Vps33b pathogenic mutations preferentially affect VIPAS39/SPE-39-positive endosomes.","date":"2013","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/23918659","citation_count":23,"is_preprint":false},{"pmid":"31125123","id":"PMC_31125123","title":"VPS33B negatively modulated by nicotine functions as a tumor suppressor in colorectal cancer.","date":"2019","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/31125123","citation_count":21,"is_preprint":false},{"pmid":"10894945","id":"PMC_10894945","title":"Cloning, mapping and expression analysis of VPS33B, the human orthologue of rat Vps33b.","date":"2000","source":"Cytogenetics and cell genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10894945","citation_count":21,"is_preprint":false},{"pmid":"34905616","id":"PMC_34905616","title":"Syntaxin 12 and COMMD3 are new factors that function with VPS33B in the biogenesis of platelet α-granules.","date":"2022","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/34905616","citation_count":21,"is_preprint":false},{"pmid":"31501156","id":"PMC_31501156","title":"Mechanism of platelet α-granule biogenesis: study of cargo transport and the VPS33B-VPS16B complex in a model system.","date":"2019","source":"Blood advances","url":"https://pubmed.ncbi.nlm.nih.gov/31501156","citation_count":20,"is_preprint":false},{"pmid":"31479177","id":"PMC_31479177","title":"Novel missense mutation in VPS33B is associated with isolated low gamma-glutamyltransferase cholestasis: Attenuated, incomplete phenotype of arthrogryposis, renal dysfunction, and cholestasis syndrome.","date":"2019","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/31479177","citation_count":19,"is_preprint":false},{"pmid":"30967781","id":"PMC_30967781","title":"Metabolomics and Lipidomics Reveal the Effect of Hepatic Vps33b Deficiency on Bile Acids and Lipids Metabolism.","date":"2019","source":"Frontiers in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/30967781","citation_count":17,"is_preprint":false},{"pmid":"37357526","id":"PMC_37357526","title":"METTL16 promotes osteosarcoma progression by downregulating VPS33B in an m6 A-dependent manner.","date":"2023","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/37357526","citation_count":16,"is_preprint":false},{"pmid":"35705052","id":"PMC_35705052","title":"Vps33B controls Treg cell suppressive function through inhibiting lysosomal nutrient sensing complex-mediated mTORC1 activation.","date":"2022","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/35705052","citation_count":16,"is_preprint":false},{"pmid":"33997178","id":"PMC_33997178","title":"VPS33B suppresses lung adenocarcinoma metastasis and chemoresistance to cisplatin.","date":"2020","source":"Genes & diseases","url":"https://pubmed.ncbi.nlm.nih.gov/33997178","citation_count":14,"is_preprint":false},{"pmid":"33029437","id":"PMC_33029437","title":"A Novel Mutation of VPS33B Gene Associated with Incomplete Arthrogryposis-Renal Dysfunction-Cholestasis Phenotype.","date":"2020","source":"Case reports in genetics","url":"https://pubmed.ncbi.nlm.nih.gov/33029437","citation_count":14,"is_preprint":false},{"pmid":"31240160","id":"PMC_31240160","title":"A novel mutation in VPS33B gene causing a milder ARC syndrome phenotype with prolonged survival.","date":"2019","source":"JIMD reports","url":"https://pubmed.ncbi.nlm.nih.gov/31240160","citation_count":13,"is_preprint":false},{"pmid":"24917129","id":"PMC_24917129","title":"Identification of novel mutations in the VPS33B gene involved in arthrogryposis, renal dysfunction, and cholestasis syndrome.","date":"2014","source":"Clinical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/24917129","citation_count":12,"is_preprint":false},{"pmid":"37062417","id":"PMC_37062417","title":"The Sec1-Munc18 protein VPS33B forms a uniquely bidirectional complex with VPS16B.","date":"2023","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/37062417","citation_count":11,"is_preprint":false},{"pmid":"24782640","id":"PMC_24782640","title":"ARC syndrome with high GGT cholestasis caused by VPS33B mutations.","date":"2014","source":"World journal of gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/24782640","citation_count":10,"is_preprint":false},{"pmid":"30561130","id":"PMC_30561130","title":"Novel VPS33B mutation in a patient with autosomal recessive keratoderma-ichthyosis-deafness syndrome.","date":"2018","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/30561130","citation_count":9,"is_preprint":false},{"pmid":"34253877","id":"PMC_34253877","title":"Hepatic Vps33b deficiency aggravates cholic acid-induced cholestatic liver injury in male mice.","date":"2021","source":"Acta pharmacologica Sinica","url":"https://pubmed.ncbi.nlm.nih.gov/34253877","citation_count":8,"is_preprint":false},{"pmid":"31777725","id":"PMC_31777725","title":"A Novel VPS33B Variant Identified by Exome Sequencing in a Patient with Arthrogryposis-Renal Dysfunction-Cholestasis Syndrome.","date":"2019","source":"Pediatric gastroenterology, hepatology & nutrition","url":"https://pubmed.ncbi.nlm.nih.gov/31777725","citation_count":8,"is_preprint":false},{"pmid":"24415890","id":"PMC_24415890","title":"Two novel VPS33B mutations in a patient with arthrogryposis, renal dysfunction and cholestasis syndrome in mainland China.","date":"2014","source":"World journal of gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/24415890","citation_count":7,"is_preprint":false},{"pmid":"33788346","id":"PMC_33788346","title":"VPS33B interacts with NESG1 to suppress cell growth and cisplatin chemoresistance in ovarian cancer.","date":"2021","source":"Cancer science","url":"https://pubmed.ncbi.nlm.nih.gov/33788346","citation_count":6,"is_preprint":false},{"pmid":"35325493","id":"PMC_35325493","title":"Platelet VPS16B is dependent on VPS33B expression, as determined in two siblings with arthrogryposis, renal dysfunction, and cholestasis syndrome.","date":"2022","source":"Journal of thrombosis and haemostasis : JTH","url":"https://pubmed.ncbi.nlm.nih.gov/35325493","citation_count":6,"is_preprint":false},{"pmid":"22677173","id":"PMC_22677173","title":"Inhibitory effect of SPE-39 due to tyrosine phosphorylation and ubiquitination on the function of Vps33B in the EGF-stimulated cells.","date":"2012","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/22677173","citation_count":4,"is_preprint":false},{"pmid":"28544027","id":"PMC_28544027","title":"A Novel VPS33B Mutation in a Patient with Arthrogryposis-Renal Dysfunction-Cholestasis Syndrome.","date":"2017","source":"Pediatric dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/28544027","citation_count":4,"is_preprint":false},{"pmid":"29046204","id":"PMC_29046204","title":"[Clinical features and VPS33B mutations in a family affected by arthrogryposis, renal dysfunction, and cholestasis syndrome].","date":"2017","source":"Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/29046204","citation_count":3,"is_preprint":false},{"pmid":"40383211","id":"PMC_40383211","title":"VPS33B-dependent exosomes modulate cellular senescence of mesenchymal stem cells via an autocrine signaling pathway.","date":"2025","source":"Experimental gerontology","url":"https://pubmed.ncbi.nlm.nih.gov/40383211","citation_count":2,"is_preprint":false},{"pmid":"36568436","id":"PMC_36568436","title":"Two novel mutations in VPS33B gene cause a milder ARC syndrome with prolonged survival in a 12-year-old patient: Case report.","date":"2022","source":"Frontiers in pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/36568436","citation_count":2,"is_preprint":false},{"pmid":"34732466","id":"PMC_34732466","title":"Vps33B in Dendritic Cells Regulates House Dust Mite-Induced Allergic Lung Inflammation.","date":"2021","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/34732466","citation_count":1,"is_preprint":false},{"pmid":"32677257","id":"PMC_32677257","title":"Hypersensitivity of Vps33B mutant flies to non-pathogenic infections is dictated by aberrant activation of p38b MAP kinase.","date":"2020","source":"Traffic (Copenhagen, Denmark)","url":"https://pubmed.ncbi.nlm.nih.gov/32677257","citation_count":1,"is_preprint":false},{"pmid":"35281816","id":"PMC_35281816","title":"Mild Phenotype of Arthrogryposis, Renal Dysfunction, and Cholestasis Syndrome 1 Caused by a Novel VPS33B Variant.","date":"2022","source":"Frontiers in genetics","url":"https://pubmed.ncbi.nlm.nih.gov/35281816","citation_count":1,"is_preprint":false},{"pmid":"34531360","id":"PMC_34531360","title":"A New Aberration in the VPS33B Gene Leads to Full-Symptom ARCS1.","date":"2021","source":"The American journal of case reports","url":"https://pubmed.ncbi.nlm.nih.gov/34531360","citation_count":1,"is_preprint":false},{"pmid":"36338198","id":"PMC_36338198","title":"Two novel mutations in the VPS33B gene in a Chinese patient with arthrogryposis, renal dysfunction and cholestasis syndrome 1: A case report.","date":"2022","source":"World journal of clinical cases","url":"https://pubmed.ncbi.nlm.nih.gov/36338198","citation_count":1,"is_preprint":false},{"pmid":"39134495","id":"PMC_39134495","title":"[Rare VPS33B gene mutation combined with GP1BA mutation causes severe decrease in plasma VWF levels: a case report and literature review].","date":"2024","source":"Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi","url":"https://pubmed.ncbi.nlm.nih.gov/39134495","citation_count":0,"is_preprint":false},{"pmid":"41686830","id":"PMC_41686830","title":"A VPS33B CRISPR knockout study: In vitro evidence of an adhesion defect.","date":"2026","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/41686830","citation_count":0,"is_preprint":false},{"pmid":"41138802","id":"PMC_41138802","title":"A novel homozygous splice-site variant in VPS33B identified as a cause of bleeding.","date":"2025","source":"Journal of thrombosis and haemostasis : JTH","url":"https://pubmed.ncbi.nlm.nih.gov/41138802","citation_count":0,"is_preprint":false},{"pmid":"42231978","id":"PMC_42231978","title":"VPS33B regulates MHC class II antigen presentation in dendritic cells to drive CD4 T cell immunity.","date":"2026","source":"iScience","url":"https://pubmed.ncbi.nlm.nih.gov/42231978","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.06.04.657864","title":"Mechanobiological proximal tubular defects in ARC syndrome: A  <i>VPS33B</i>  CRISPR knockout study","date":"2025-06-04","source":"bioRxiv","url":"https://doi.org/10.1101/2025.06.04.657864","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":27725,"output_tokens":7198,"usd":0.095573,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":16392,"output_tokens":5914,"usd":0.114905,"stage2_stop_reason":"end_turn"},"total_usd":0.210478,"stage1_batch_id":"msgbatch_01UT1AahFPCAyn2uVweS7A9z","stage2_batch_id":"msgbatch_01HuKWtKNT4Pqj1bc8eEP5RV","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2004,\n      \"finding\": \"VPS33B encodes a homolog of yeast class C vacuolar protein sorting gene Vps33 and contains a Sec1-like domain important in regulation of vesicle-to-target SNARE complex formation and subsequent membrane fusion. Loss-of-function mutations cause ARC syndrome.\",\n      \"method\": \"Positional cloning, mutation identification in 14 kindreds, sequence domain analysis\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — disease-gene linkage with domain analysis; mechanistic inference from homology supported by disease mutations, single study\",\n      \"pmids\": [\"15052268\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"VPS33B is required for megakaryocyte and platelet alpha-granule biogenesis but not granule secretion. VPS33B colocalizes with alpha-granule markers and late endosomes/lysosomes in megakaryocytes, and VPS33B protein is absent in ARC patient fibroblasts and megakaryocytes, resulting in complete absence of alpha-granules and loss of both soluble and membrane-bound alpha-granule proteins.\",\n      \"method\": \"Immunofluorescence microscopy, immunoblotting, platelet ultrastructural analysis, platelet aggregation assays in ARC patients\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (immunofluorescence, electron microscopy, functional aggregation assays, immunoblotting) in patient samples\",\n      \"pmids\": [\"16123220\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Zebrafish vps33b acts downstream of the hnf6/vhnf1 transcription factor pathway to regulate biliary development; vhnf1 directly binds the vps33b promoter as shown by EMSA, and vps33b knockdown causes bile duct paucity and impaired intestinal lipid absorption.\",\n      \"method\": \"Morpholino knockdown in zebrafish, EMSA, gene expression analysis, reporter assay in mammalian liver cells\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — EMSA for direct promoter binding, morpholino KD phenotype, multiple methods in single lab\",\n      \"pmids\": [\"16284120\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"VPS33B deficiency results in failure of lamellar granule secretion at the granular-cornified cell layer boundary in skin, with lamellar granules becoming entombed in cornified cells rather than being secreted, causing ichthyosis in ARC syndrome.\",\n      \"method\": \"Ultrastructural electron microscopy of patient skin, VPS33B mutation sequencing and splice analysis\",\n      \"journal\": \"Archives of dermatology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ultrastructural analysis directly linking VPS33B mutation to lamellar granule secretion defect, single lab\",\n      \"pmids\": [\"18347289\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"VPS33B interacts with VIPAS39 (SPE-39). Wild-type and disease-causing mutations in VIPAS39 and Vps33B were studied; most ARC mutations do not prevent the VIPAS39-Vps33B interaction, but all tested mutants alter subcellular localization of Vps33B to VIPAS39-positive endosomes and some fragment VIPAS39-positive endosomes.\",\n      \"method\": \"Yeast two-hybrid, co-immunoprecipitation, quantitative fluorescent microscopy\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — yeast two-hybrid and co-IP with localization, single lab, multiple orthogonal methods\",\n      \"pmids\": [\"23918659\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"VPS33B binds to VPS16B (encoded by C14orf133/VIPAS39); this interaction was identified by yeast two-hybrid, mass spectrometry, and coimmunoprecipitation. VPS16B colocalizes with markers of the trans-Golgi network, late endosomes, and alpha-granules in megakaryocytic Dami cells, similar to VPS33B, and VPS16B mutations cause alpha-granule biogenesis defects identical to VPS33B mutations.\",\n      \"method\": \"Yeast two-hybrid, mass spectrometry, coimmunoprecipitation, immunofluorescence microscopy, immunoblotting, patient platelet electron microscopy\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — multiple orthogonal methods (Y2H, MS, co-IP, microscopy, patient samples) in one study with reciprocal validation\",\n      \"pmids\": [\"23002115\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Association of VPS33B with SPE-39 (VIPAS39) inhibits ubiquitination of SPE-39 following EGF stimulation, stabilizing SPE-39. Tyrosine phosphorylation of SPE-39 at Tyr-11 regulates its ubiquitination. VPS33B and SPE-39 have opposing effects on EGF receptor downregulation in EGF-stimulated cells.\",\n      \"method\": \"Ubiquitination assays, phosphorylation analysis, co-immunoprecipitation, EGF receptor downregulation assays in COS-7 cells\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP and functional assays showing opposing roles on EGFR downregulation, single lab\",\n      \"pmids\": [\"22677173\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"VPS33B deficiency in mouse megakaryocytes causes accumulation of large vacuoles and reduction in mature type-II multivesicular bodies (MVB II), with alpha-granule proteins underrepresented in MVB II and proplatelet extensions, demonstrating that VPS33B is required for protein trafficking into alpha-granule progenitor organelles and MVB maturation.\",\n      \"method\": \"Tamoxifen-inducible conditional Vps33b knockout mouse model, conventional and immuno-electron microscopy, immunofluorescence, platelet aggregation and secretion assays, tail bleeding\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — inducible KO mouse model with immuno-EM defining specific organelle defect, multiple orthogonal methods\",\n      \"pmids\": [\"25947942\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"VPS33B depletion in HeLa cells leads to accumulation of late endosomes in the perinuclear region and impairs late endosomal-lysosomal fusion, resulting in decreased delivery of endocytosed cargo to lysosomes and reduced cargo degradation.\",\n      \"method\": \"siRNA knockdown, fluorescence and electron microscopy, BSA-gold endocytosis tracking, organelle quantification\",\n      \"journal\": \"Traffic (Copenhagen, Denmark)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods (fluorescence and EM, cargo tracking) in KD cells, demonstrating specific late endosome–lysosome fusion defect\",\n      \"pmids\": [\"26403612\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"VPS33B binds directly to the integrin beta subunit. VPS33B overexpression in CHO cells potentiates alphaIIbbeta3 outside-in signaling but not inside-out signaling. Megakaryocyte/platelet-specific VPS33B conditional KO mice show impaired platelet spreading on fibrinogen, defective clot retraction, reduced platelet aggregation, and defective fibrinogen endocytosis. VPS33B acts upstream of the RhoA-ROCK-MLC and Rac1-dependent pathways.\",\n      \"method\": \"Co-immunoprecipitation/direct binding assay, CHO cell overexpression, conditional KO mouse model, platelet spreading/aggregation/clot retraction assays, FeCl3 thrombosis model, tail bleeding\",\n      \"journal\": \"Circulation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct binding assay, conditional KO with multiple functional readouts and epistasis to RhoA/Rac1 pathways\",\n      \"pmids\": [\"26399659\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"VPS33B interacts with VIPAS39 (SPE-39) and with alpha-tubulin and SEC22B; pull-down experiments showed VIPAS39 binds intact VPS33B whereas alpha-tubulin and SEC22B separately interact with the Sec1-like domains of VPS33B. VPS33B deficiency disrupts redistribution of Vipas39 and Sec22b to proplatelets and interrupts co-localization of Sec22b with VWF-positive vesicles in megakaryocytes.\",\n      \"method\": \"Co-immunoprecipitation, mass spectrometry, pull-down assay, immunoblotting in HEK293T cells; conditional Vps33b KO mice; immunofluorescence microscopy\",\n      \"journal\": \"The Journal of pathology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pull-down and co-IP identifying domain-specific interactions, supported by KO mouse localization data, single lab\",\n      \"pmids\": [\"27319744\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Drosophila and mammalian Vps33B proteins are required for maturation of phagosomes and endosomes following microbial (PRR) recognition. Vps33B deficiency specifically impairs clearance of endosomes containing internalized PRRs, resulting in enhanced and prolonged inflammatory signaling. Vps33B loss had no effect on trafficking of endosomes containing non-microbial cargo.\",\n      \"method\": \"Drosophila and mammalian Vps33B mutant/knockdown models, phagosome/endosome maturation assays, TLR signaling assays, cytokine/inflammatory mediator measurements\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — replicated in two organisms with specific cargo-selective phenotype established by KO and KD with functional readouts\",\n      \"pmids\": [\"27496733\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"VPS33B controls exosome maturation and secretion in hematopoietic stem cells. VPS33B co-exists in exosomes with GDI2, VPS16B, FLOT1, and other exosome markers. Mechanistically, VPS33B interacts with the GDI2/RAB11A/RAB27A pathway to regulate trafficking of secretory proteins as exosomes. VPS33B deletion in mouse or human HSCs results in impaired exosome maturation and secretion and loss of stemness.\",\n      \"method\": \"Conditional VPS33B deletion in mouse and human HSCs, exosome purification and characterization, co-immunoprecipitation, rescue experiments with purified exosomes\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — KO in two species, co-IP identifying pathway components (GDI2/RAB11A/RAB27A), rescue experiment, multiple orthogonal methods\",\n      \"pmids\": [\"27797340\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"The p.Gly131Glu mutant VPS33B has reduced coimmunoprecipitation and colocalization with Rab11a and Rab25 and fails to rescue LH3 (lysyl hydroxylase 3) trafficking. Wild-type VPS33B interacts with Rab11a and Rab25 proteins and is involved in trafficking of the collagen-modifying enzyme LH3; deficiency leads to deficient LH3-specific collagen lysine modifications.\",\n      \"method\": \"Co-immunoprecipitation, colocalization microscopy, LH3 trafficking rescue assay, collagen lysine modification analysis in patient urine and fibroblasts, VPS33B mutant construct analysis\",\n      \"journal\": \"The Journal of investigative dermatology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (co-IP, colocalization, functional rescue assay, biochemical modification analysis) linking VPS33B-Rab11a/Rab25 interaction to LH3 trafficking\",\n      \"pmids\": [\"28017832\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Liver-specific Vps33b deletion in mice causes mislocalisation of ATP-binding cassette (ABC) proteins that are trafficked to the apical membrane via Rab11a-positive recycling endosomes, resulting in loss of structural and functional hepatocyte polarity. VPS33B interacts with RAB11A at recycling endosomes. Gene transfer with AAV vectors partially rescued these defects.\",\n      \"method\": \"Liver-specific conditional Vps33b KO mouse, bile/plasma metabolite analysis by mass spectrometry, immunostaining, light/transmission electron microscopy, AAV gene rescue\",\n      \"journal\": \"Journal of hepatology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional KO with functional (bile transport), structural (EM), and molecular (protein localization) readouts plus gene rescue, multiple orthogonal methods\",\n      \"pmids\": [\"28082148\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"VPS33B and VIPAR are essential for epidermal lamellar body biogenesis and function. Vps33b and Vipar deficient mouse skin shows abnormal lamellar body morphology, disrupted localisation of lamellar body cargo, increased corneocyte thickness, decreased cornified envelope thickness, and reduced lipid deposition, causing impaired epidermal barrier.\",\n      \"method\": \"Vps33b and Vipar KO mice, histology, immunofluorescence, electron microscopy, primary cell culture\",\n      \"journal\": \"Biochimica et biophysica acta. Molecular basis of disease\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — two KO mouse models with histological, ultrastructural, and immunofluorescence analysis, multiple orthogonal methods\",\n      \"pmids\": [\"29409756\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"VPS33B does not associate with CORVET or HOPS complex subunits. Instead, VPS33B forms a distinct and small complex with VIPAR. VPS33B also interacts directly with CCDC22, a member of the CCC complex, but this interaction is transient rather than forming a stable complex. CCDC22 does not co-fractionate with VPS33B and VIPAR in gel filtration, and the VPS33B-VIPAR complex is considerably smaller than CORVET/HOPS.\",\n      \"method\": \"BioID proximity biotinylation assay, gel filtration chromatography, comparative interactome analysis of VPS33A and VPS33B\",\n      \"journal\": \"Journal of molecular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — BioID and gel filtration provide orthogonal evidence; single lab; negative result for CORVET/HOPS association informative\",\n      \"pmids\": [\"29778605\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"The VPS33B-VPS16B complex forms a distinct small complex with the same hydrodynamic radius as the recombinant heterodimer purified from bacteria. In megakaryocyte cells, VPS33B deficiency results in alpha-granule cargo (PF4, VWF, P-selectin) degradation in lysosomes rather than delivery to alpha-granules. The VPS33B-VPS16B complex localizes to the recycling endosome, identifying the recycling endosome as a key intermediate compartment in alpha-granule biogenesis. VPS16B steady-state levels are reduced in VPS33B-KO cells, indicating VPS16B is destabilized without its partner.\",\n      \"method\": \"CRISPR/Cas9 KO in iPSC-derived immortalized megakaryocyte cells (imMKCLs), size exclusion chromatography, recombinant protein purification from bacteria, GFP-VPS33B reconstitution, cargo trafficking analysis, lysosomal inhibitor experiments\",\n      \"journal\": \"Blood advances\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — recombinant protein purification, CRISPR KO, reconstitution with GFP-VPS33B, and lysosomal degradation assays provide multiple orthogonal mechanistic insights in one study\",\n      \"pmids\": [\"31501156\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"A missense mutation p.Cys576Arg in VPS33B abolishes interaction with VIPAS39 in vitro, as demonstrated by co-immunoprecipitation.\",\n      \"method\": \"In vitro co-immunoprecipitation with mutant VPS33B constructs, protein expression analysis\",\n      \"journal\": \"Human mutation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — single co-IP experiment demonstrating abolished VIPAR interaction for specific mutation, single lab\",\n      \"pmids\": [\"31479177\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Vps33B loss-of-function in Drosophila results in hypersensitivity to infection driven by aberrant p38b MAP kinase activation downstream of PGRP-LC receptor. p38b MAPK modulates endosomal trafficking of PGRP-LC and phagocytosis of bacteria; constitutively active p38b enhances accumulation of endocytosed PGRP-LC, and p38b is required for macropinocytosis-mediated downregulation of immune receptors.\",\n      \"method\": \"Drosophila Vps33B mutant flies, p38b MAPK epistasis experiments (constitutively active/dominant negative constructs), endosomal trafficking assays, phagocytosis assays, survival assays\",\n      \"journal\": \"Traffic (Copenhagen, Denmark)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis with constitutively active/dominant negative constructs and functional assays, single lab in Drosophila model\",\n      \"pmids\": [\"32677257\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"VPS16B/VPS33B complex physically associates with Syntaxin 12 (Stx12), a SNARE protein mediating vesicle fusion at endosomes. VPS16B/VPS33B also binds CCDC22 (CCC complex). CCDC22 competes with Stx12 for binding to VPS16B/VPS33B, suggesting a hand-off mechanism between endosomal entry (Stx12-mediated fusion) and exit (CCC-mediated retrieval). COMMD3-containing CCC complex deficiency causes reduced alpha-granule numbers and loss of alpha-granule proteins, with P-selectin trafficked through the cell surface in a COMMD3-dependent manner.\",\n      \"method\": \"Co-immunoprecipitation, CRISPR/Cas9 KO of Stx12 and COMMD3/CCDC22 in megakaryocyte cells, immunofluorescence, alpha-granule protein quantitation, flow cytometry\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple co-IPs and CRISPR KOs with functional granule phenotypes, competition assay for hand-off mechanism, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"34905616\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Treg-specific depletion of Vps33B in mice results in defective Treg cell suppressive function and acquisition of effector phenotype. Mechanistically, Vps33B binds the lysosomal nutrient-sensing complex (LYNUS) and promotes late endosome-lysosome fusion and clearance of LYNUS-containing late endosome/lysosomes, thereby suppressing mTORC1 activation. Vps33B deficiency causes disordered endosome-lysosome fusion, accumulation of LYNUS, elevated mTORC1 activation, and hyper-glycolytic metabolism in Treg cells.\",\n      \"method\": \"Treg-specific conditional KO mice, mTORC1 activity assays, glycolytic metabolism measurement, endolysosomal fusion assays, co-immunoprecipitation of Vps33B with LYNUS components, T cell suppression assays, tumor models\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional KO, co-IP demonstrating LYNUS interaction, mTORC1 functional readout, multiple orthogonal mechanistic methods\",\n      \"pmids\": [\"35705052\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"In ARC syndrome patient platelets with VPS33B loss-of-function, VPS16B protein expression is also lost, indicating that stable expression of VPS16B in platelets and megakaryocytes is dependent on VPS33B.\",\n      \"method\": \"Immunoblotting of patient platelets, electron microscopy, genetic analysis of novel VPS33B variant\",\n      \"journal\": \"Journal of thrombosis and haemostasis : JTH\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single patient primary cell immunoblotting; finding consistent with CRISPR data from other labs but single case\",\n      \"pmids\": [\"35325493\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Human VPS33B-VPS16B forms a high molecular weight complex (~315 kDa) with a VPS33B:VPS16B ratio of 2:3 and a uniquely bidirectional two-lobed structure, each lobe containing a VPS33B molecule oriented in opposite directions. This architecture allows VPS33B at each end to potentially interact with separate SNARE bundles/SNAREpins. The ARC-causing variant L30P disrupts complex formation, whereas S243F and H344D do not. Truncated VPS16B (amino acids 143-316) is sufficient to form a complex with VPS33B.\",\n      \"method\": \"Recombinant protein expression in yeast, circular dichroism, SEC-MALS, quantitative immunoblotting, small-angle X-ray scattering, negative-staining EM, avidin tagging, ARC variant expression analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — reconstitution with multiple structural methods (CD, SEC-MALS, SAXS, negative-stain EM) plus mutagenesis establishing structure-function relationships\",\n      \"pmids\": [\"37062417\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"METTL16 methyltransferase induces m6A modification of VPS33B mRNA, impairing VPS33B transcript stability and reducing VPS33B protein levels. This was identified as a downstream regulatory mechanism controlling VPS33B expression in osteosarcoma.\",\n      \"method\": \"m6A modification assays, mRNA stability assays, METTL16 knockdown/overexpression, VPS33B knockdown rescue experiments\",\n      \"journal\": \"Journal of cellular physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct m6A modification of VPS33B mRNA identified with functional stability readout, single lab\",\n      \"pmids\": [\"37357526\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"VPS33B knockout in proximal tubular epithelial cells (RPTEC-TERT1) causes a 'peeling' phenotype with altered cell-matrix adhesion and transcriptional changes in adhesion-related genes.\",\n      \"method\": \"CRISPR/Cas9 KO, brightfield imaging, immunostaining, RNA sequencing, cell detachment assays\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — CRISPR KO with multiple methods (imaging, RNA-seq, functional assay) but single lab; transcriptional changes without direct molecular mechanism identified\",\n      \"pmids\": [\"41686830\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"VPS33B is required for optimal MHC class II antigen presentation in dendritic cells. VPS33B-deficient DCs predominantly express MHC class II loaded with invariant chain degradation intermediates rather than mature peptide-loaded complexes, impairing CD4 T cell priming while not affecting MHC class I-dependent CD8 T cell priming.\",\n      \"method\": \"DC-specific conditional KO, MHC class II peptide presentation assays, CD4 and CD8 T cell priming assays, flow cytometry, immunostaining\",\n      \"journal\": \"iScience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional KO with specific mechanistic readout (invariant chain degradation intermediate accumulation), selective class II vs class I effect established by multiple T cell assays\",\n      \"pmids\": [\"42231978\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"VPS33B is a Sec1/Munc18 family protein that forms a uniquely bidirectional ~315 kDa heteromeric complex (2:3 ratio) with VPS16B/VIPAR, enabling interaction with SNARE complexes at both ends to regulate vesicle-to-target membrane fusion; it acts at recycling endosomes and late endosomal-lysosomal fusion steps to direct trafficking of diverse cargo—including alpha-granule proteins in megakaryocytes, apical ABC transporters in hepatocytes, lamellar body contents in keratinocytes, collagen-modifying enzyme LH3, PRR-containing endosomes in innate immune cells, and MHC class II complexes in dendritic cells—through interactions with Rab11a, Rab25, Rab27a, GDI2, SNARE proteins (SEC22B, Syntaxin 12), integrin beta subunits, the CCC/COMMD3 complex, and the lysosomal nutrient-sensing complex (LYNUS), with loss of function causing ARC syndrome due to defective vesicular protein sorting across multiple tissues.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"VPS33B is a Sec1/Munc18 (SM)-family vesicle trafficking regulator that controls protein sorting at recycling endosomes and the late endosome–lysosome interface across multiple specialized cell types [#0, #8]. Rather than associating with the canonical CORVET/HOPS tethering complexes, it forms a distinct, stable heteromeric complex with VPS16B/VIPAS39 (VIPAR), a partnership essential for its activity and for the reciprocal stabilization of VPS16B, which is destabilized and lost when VPS33B is absent [#5, #16, #17, #22]. Structurally this complex is a ~315 kDa, two-lobed bidirectional assembly with a 2:3 VPS33B:VPS16B stoichiometry, an architecture that positions a VPS33B molecule at each end to engage SNARE machinery, consistent with its physical association with SNARE proteins SEC22B and Syntaxin 12 [#10, #20, #23]. The complex directs cargo through Rab-dependent recycling pathways—binding Rab11a and Rab25 and the GDI2/RAB11A/RAB27A axis—to traffic diverse cargo: alpha-granule proteins in megakaryocytes, apical ABC transporters in hepatocytes, lamellar body contents in keratinocytes, and the collagen-modifying enzyme LH3 [#12, #13, #14, #15]. At the late endosome–lysosome step VPS33B promotes fusion and cargo clearance, controlling delivery of endocytosed cargo for degradation, clearance of pattern-recognition-receptor-containing endosomes to limit inflammatory signaling, turnover of the LYNUS complex to restrain mTORC1 activation in regulatory T cells, and MHC class II maturation in dendritic cells [#8, #11, #21, #26]. In megakaryocytes loss of VPS33B misroutes alpha-granule cargo to lysosomal degradation rather than to alpha-granule progenitor organelles, defining the recycling endosome as a key biogenesis intermediate; a competitive hand-off between Syntaxin 12 and the COMMD3/CCC retrieval complex couples endosomal entry to exit [#7, #17, #20]. Loss-of-function mutations in VPS33B cause ARC syndrome (arthrogryposis–renal dysfunction–cholestasis), reflecting defective vesicular sorting across megakaryocytes, hepatocytes, and skin [#0, #1, #3].\",\n  \"teleology\": [\n    {\n      \"year\": 2004,\n      \"claim\": \"Established the molecular identity of VPS33B as a Sec1-like SM-family trafficking protein and linked its loss of function to a human multisystem disorder, framing the gene as a regulator of SNARE-mediated membrane fusion.\",\n      \"evidence\": \"Positional cloning and mutation analysis in 14 ARC kindreds with sequence domain analysis\",\n      \"pmids\": [\"15052268\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct biochemical demonstration of SNARE regulation not shown\", \"Tissue-specific trafficking roles undefined\", \"No interacting partners identified\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Demonstrated that VPS33B is required for alpha-granule biogenesis but not secretion, providing the first concrete cellular trafficking defect underlying an ARC phenotype.\",\n      \"evidence\": \"Immunofluorescence, immunoblotting, platelet ultrastructure and aggregation assays in ARC patient cells\",\n      \"pmids\": [\"16123220\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular partners mediating granule cargo sorting unknown\", \"Compartment where sorting fails not yet defined\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Placed vps33b downstream of a transcriptional cascade in biliary development, connecting its trafficking function to organ morphogenesis.\",\n      \"evidence\": \"Morpholino knockdown in zebrafish, EMSA promoter binding, reporter assays\",\n      \"pmids\": [\"16284120\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism connecting trafficking to bile duct formation unresolved\", \"Mammalian relevance of transcriptional control untested\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Extended the secretory trafficking defect to skin, showing lamellar granule secretion fails in VPS33B deficiency, explaining the ichthyosis component of ARC.\",\n      \"evidence\": \"Ultrastructural EM of patient skin with mutation/splice analysis\",\n      \"pmids\": [\"18347289\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular step blocking lamellar granule secretion undefined\", \"Partner proteins not identified\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Identified VPS16B/VIPAS39 as the principal VPS33B partner, showing both proteins co-localize and that VIPAS39 mutations phenocopy VPS33B loss, establishing the functional complex.\",\n      \"evidence\": \"Yeast two-hybrid, mass spectrometry, co-IP, immunofluorescence, patient platelet EM\",\n      \"pmids\": [\"23002115\", \"23918659\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Stoichiometry and architecture of complex unknown\", \"Whether complex includes CORVET/HOPS subunits unresolved\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Linked VPS33B-VIPAS39 association to receptor regulation, showing the interaction stabilizes VIPAS39 and the two proteins exert opposing effects on EGFR downregulation.\",\n      \"evidence\": \"Ubiquitination/phosphorylation assays, co-IP and EGFR downregulation assays in COS-7 cells\",\n      \"pmids\": [\"22677173\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Physiological relevance of opposing EGFR effects unclear\", \"Connection to multisystem ARC phenotypes not established\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Defined the organellar step VPS33B controls in megakaryocytes (MVB maturation/cargo entry) and in generic cells (late endosome–lysosome fusion), converging on a conserved fusion function.\",\n      \"evidence\": \"Inducible Vps33b KO mouse with immuno-EM; siRNA knockdown with cargo tracking and EM in HeLa\",\n      \"pmids\": [\"25947942\", \"26403612\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct SNARE/fusion machinery at these steps not yet identified\", \"Cargo selectivity mechanism unclear\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Showed VPS33B binds the integrin beta subunit and functions in platelet outside-in signaling and fibrinogen endocytosis, extending its role beyond granule biogenesis to receptor trafficking and cytoskeletal signaling.\",\n      \"evidence\": \"Direct binding assay, CHO overexpression, conditional KO mice, spreading/clot retraction/thrombosis assays\",\n      \"pmids\": [\"26399659\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of integrin binding undefined\", \"How trafficking role couples to RhoA/Rac1 signaling unresolved\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Mapped domain-specific interactions, showing VIPAS39 binds intact VPS33B while alpha-tubulin and SEC22B engage the Sec1-like domains, and that VPS33B operates within Rab11a/Rab25 and GDI2/RAB11A/RAB27A pathways.\",\n      \"evidence\": \"Co-IP, MS, pull-down in HEK293T; conditional KO mice; HSC exosome studies with rescue; LH3 trafficking rescue assays\",\n      \"pmids\": [\"27319744\", \"27797340\", \"28017832\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How Rab handoffs are coordinated mechanistically unclear\", \"Whether SNARE binding is direct and which SNAREs predominate per tissue undefined\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Established cargo-selective, infection-specific function, showing VPS33B is required for maturation of PRR-containing endosomes/phagosomes and restrains inflammatory signaling, conserved from Drosophila to mammals.\",\n      \"evidence\": \"Drosophila and mammalian mutant/knockdown models, maturation assays, TLR signaling and cytokine measurements\",\n      \"pmids\": [\"27496733\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism distinguishing microbial from non-microbial cargo unknown\", \"Upstream sensors triggering selective VPS33B engagement undefined\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Demonstrated hepatocyte apical polarity depends on VPS33B-mediated Rab11a recycling-endosome trafficking of ABC transporters, with AAV gene transfer offering partial rescue.\",\n      \"evidence\": \"Liver-specific conditional KO, bile metabolite MS, immunostaining, EM, AAV rescue\",\n      \"pmids\": [\"28082148\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct VPS33B-cargo recognition mechanism unresolved\", \"Durability/scalability of gene therapy untested\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Clarified the complex identity: VPS33B does not associate with CORVET/HOPS but forms a small VPS33B-VIPAR complex with only transient CCC (CCDC22) contact, distinguishing it biochemically from its paralog VPS33A.\",\n      \"evidence\": \"BioID, gel filtration, comparative VPS33A/VPS33B interactome analysis\",\n      \"pmids\": [\"29778605\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Precise stoichiometry not resolved here\", \"Functional consequence of transient CCC contact undefined\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Confirmed VPS33B-VIPAR jointly drive epidermal lamellar body biogenesis and barrier formation in mammals, validating the shared-complex model in skin.\",\n      \"evidence\": \"Vps33b and Vipar KO mice, histology, immunofluorescence, EM, primary culture\",\n      \"pmids\": [\"29409756\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular cargo-loading step into lamellar bodies undefined\", \"Lipid-handling mechanism not detailed\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Resolved that the VPS33B-VPS16B complex is a discrete heterodimer-sized assembly localizing to recycling endosomes, and that without it alpha-granule cargo is misrouted to lysosomal degradation, identifying the recycling endosome as the key biogenesis intermediate.\",\n      \"evidence\": \"CRISPR KO in iPSC-derived megakaryocytes, SEC, recombinant protein, GFP-reconstitution, lysosomal inhibition\",\n      \"pmids\": [\"31501156\", \"31479177\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Atomic structure not yet determined here\", \"Mechanism diverting cargo away from lysosome unknown\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Defined an entry/exit hand-off, showing CCDC22 (CCC) competes with Syntaxin 12 for the VPS16B/VPS33B complex and that COMMD3-containing CCC controls alpha-granule cargo retrieval, integrating SNARE-mediated fusion with endosomal sorting.\",\n      \"evidence\": \"Co-IP, CRISPR KO of Stx12 and COMMD3/CCDC22, immunofluorescence, granule protein quantitation\",\n      \"pmids\": [\"34905616\", \"35325493\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Spatiotemporal regulation of the competition unresolved\", \"Whether hand-off operates identically in non-platelet tissues untested\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Revealed an immunometabolic role: VPS33B clears LYNUS-containing late endosomes/lysosomes to suppress mTORC1, sustaining regulatory T cell suppressive function and restraining glycolysis.\",\n      \"evidence\": \"Treg-specific conditional KO, mTORC1 and glycolysis assays, endolysosomal fusion assays, LYNUS co-IP, tumor models\",\n      \"pmids\": [\"35705052\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct LYNUS binding interface undefined\", \"Whether mTORC1 control generalizes to other cell types untested\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Determined the bidirectional two-lobed ~315 kDa 2:3 architecture of the complex, providing the structural rationale for VPS33B engaging SNARE bundles at both ends, and mapped ARC variants that do or do not disrupt assembly.\",\n      \"evidence\": \"Recombinant expression, CD, SEC-MALS, SAXS, negative-stain EM, avidin tagging, ARC variant analysis\",\n      \"pmids\": [\"37062417\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"High-resolution structure with bound SNAREs lacking\", \"Whether both lobes engage SNAREs simultaneously in vivo untested\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Identified post-transcriptional control of VPS33B via METTL16-mediated m6A modification reducing transcript stability, providing a regulatory input in osteosarcoma.\",\n      \"evidence\": \"m6A and mRNA stability assays, METTL16 manipulation, VPS33B knockdown rescue\",\n      \"pmids\": [\"37357526\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Physiological context of this regulation beyond osteosarcoma unclear\", \"Downstream trafficking consequences not detailed\"]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"Extended VPS33B function to dendritic cell MHC class II maturation, showing its loss causes accumulation of invariant-chain intermediates and selectively impairs CD4 priming, and to renal epithelial cell-matrix adhesion.\",\n      \"evidence\": \"DC-specific and RPTEC-TERT1 CRISPR/conditional KO, MHC peptide presentation and T cell priming assays, RNA-seq, adhesion assays\",\n      \"pmids\": [\"42231978\", \"41686830\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular step in invariant chain processing controlled by VPS33B undefined\", \"Direct adhesion-pathway mechanism in renal cells not identified\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How the bidirectional VPS33B-VPS16B complex selects distinct cargo and SNARE partners across tissues, and the high-resolution structural basis for SNARE engagement, remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No co-structure of the complex with SNAREs or Rab effectors\", \"Mechanism of tissue-specific cargo selectivity unknown\", \"Whether both lobes function simultaneously or sequentially undefined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [10, 20, 23]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 8]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005768\", \"supporting_discovery_ids\": [1, 8, 13, 17]},\n      {\"term_id\": \"GO:0005764\", \"supporting_discovery_ids\": [8, 17, 21]},\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [7, 12]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-5653656\", \"supporting_discovery_ids\": [8, 11, 14, 17]},\n      {\"term_id\": \"R-HSA-9609507\", \"supporting_discovery_ids\": [13, 14]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [11, 21, 26]},\n      {\"term_id\": \"R-HSA-109582\", \"supporting_discovery_ids\": [1, 7, 9]}\n    ],\n    \"complexes\": [\n      \"VPS33B-VPS16B/VIPAR complex\"\n    ],\n    \"partners\": [\n      \"VIPAS39\",\n      \"SEC22B\",\n      \"STX12\",\n      \"RAB11A\",\n      \"RAB25\",\n      \"GDI2\",\n      \"CCDC22\",\n      \"ITGB3\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}